HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Prognosis and current treatment of dermatomyositis].

Abstract
The present revision has been carried out in order to final out to what extent corticosteroids have improved the vital and functional prognosis of dermatomyositis. Over the sixties and in the early seventies, statistical tables have not shown any substantial differences compared with those of the pre-steroid era. It has been observed since 1973 that early treatment with high doses (1-2 mg of prednisone per kg per day) clearly improves the vital prognosis of infantile dermatomyositis, but not the functional one. In adults, there is less experience and the problem always exists of a possible underlying neoplasm. In cases with resistance to corticosteroids, the association of immunosuppressors, particulary methotrexate, has begun to be tested. There is no proved effective treatment of calcinosis which results in functional recovery.
AuthorsE Sánchez Yus
JournalMedicina cutanea ibero-latino-americana (Med Cutan Ibero Lat Am) Vol. 5 Issue 5 Pg. 367-72 ( 1977) ISSN: 0210-5187 [Print] Portugal
Vernacular TitlePronóstico y tratamiento actual de la dermatomiositis.
PMID368460 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Prednisone
Topics
  • Adult
  • Body Weight
  • Calcinosis (chemically induced)
  • Child
  • Dermatomyositis (drug therapy)
  • Humans
  • Prednisone (administration & dosage, adverse effects)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: